Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating the efficacy and safety of LEO 152020 tablets in adults with moderate to severe atopic dermatitis; results have bee…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2) [Phase 3]
Phase 3 trial (EPIONE2) evaluating tradipitant vs placebo for atopic dermatitis was terminated with results posted in May 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Use of a Mobile Health App in Managing Pediatric Atopic Dermatitis [NA]
This document notes the completion of a clinical trial evaluating a mobile health app for managing pediatric atopic dermatitis. The update d…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE) [Phase 3]
Phase 3 EPIONE trial evaluating tradipitant versus placebo in atopic dermatitis has completed and posted results on 2024-05-13.
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis [Phase 1]
A phase 1 study of LY3844583 in healthy participants and individuals with atopic dermatitis was terminated; the document does not report stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis. [Phase 2]
Phase 2 trial evaluating CMK389 for moderate to severe Atopic Dermatitis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2a trial is evaluating the efficacy and safety of OpSCF in adults with moderate to severe atopic dermatitis; current trial status is…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Skin Pathology Assessment With Optical Technologies
This document reports the completion of a clinical trial evaluating optical technologies for assessing skin pathology in patients with atopi…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China [Phase 2]
A Phase 2 trial evaluating CBP-201 for moderate-to-severe atopic dermatitis in China has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]
ASLAN Pharmaceuticals reports that the Phase 2b trial of ASLAN004 for adults with moderate-to-severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis [NA]
A completed clinical trial evaluating an electrolyzed water spray for mild senile groin eczema, neurodermatitis, and psoriasis; results are …
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Apremilast 30 mg Twice Daily (BID) Combined With Dupilumab [Phase 2]
Phase 2 trial evaluating apremilast 30 mg twice daily in combination with dupilumab for atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models [Phase 4]
Phase 4 trial update focusing on optimizing atopic dermatitis treatment using predictive models to determine the need for second-line system…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children [Phase 3]
Phase 3 clinical trial update on Blue Cap showing efficacy and safety for treating atopic dermatitis in children.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Jaktinib Hydrochloride Cream For Atopic Dermatitis [Phase 1, Phase 2]
Clinical trial update for jaktinib hydrochloride cream in atopic dermatitis across Phase 1 and Phase 2, with study completed.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update evaluating safety and efficacy in moderate to severe subacute and chronic atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Dupixent and Narrowband UVB for Atopic Dermatitis [Phase 4]
Phase 4 clinical trial update examining Dupixent in combination with Narrowband UVB for atopic dermatitis, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis [Phase 3]
A Phase III extended clinical trial evaluating jaktinib hydrochloride tablets for moderate to severe atopic dermatitis is being conducted, w…
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis [Phase 2]
Phase 2a study evaluating safety, tolerability, and pharmacokinetics of topically applied PRN473 (SAR444727) in mild-to-moderate atopic derm…
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients [Phase 2]
Phase 2 clinical trial update for Hemay808 in atopic dermatitis has been completed.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Study of Hemay005 in Adult With Atopic Dermatitis [Phase 2]
A Phase 2 trial update for Hemay005 in adults with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children [Phase 4]
Phase 4 study exploring optimal cetirizine dosing for allergic diseases in Chinese children.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis [NA]
Clinical trial update indicates completed study evaluating Cetaphil Restoraderm on young children with atopic dermatitis; results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis [Phase 3]
Phase 3 clinical trial update for MG-K10, a humanized monoclonal antibody, investigated in patients with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: A Study of MG-K10 in Subjects With Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for MG-K10 in subjects with Atopic Dermatitis.